Seasoned biotech veteran launches new company: "This will be so much fun"
At the turn of his 65th year, experienced biotech veteran Peter Nordkild is still up for an adventure. He and two colleagues have founded a new Danish biotech company which will develop drugs for the treatment of a long list of common ailments, and eventually multiresistant viruses and bacteria.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.